Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-02
DOI
10.3389/fonc.2020.01361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Visualizing and interpreting cancer genomics data via the Xena platform
- (2020) Mary J. Goldman et al. NATURE BIOTECHNOLOGY
- Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma
- (2019) Saeed Daneshmandi et al. Cancers
- Current insights into the epigenetic mechanisms of skin cancer
- (2019) Yanqi Sang et al. Dermatologic Therapy
- Role of CXCR3 signaling in response to anti-PD-1 therapy
- (2019) Xiao Han et al. EBioMedicine
- Down Regulation of c-FLIPL Enhance PD-1 Blockade Efficacy in B16 Melanoma
- (2019) Yao Wang et al. Frontiers in Oncology
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- (2019) Andrea Cossarizza et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
- (2019) Crescenzo D’Alterio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Reversal of indoleamine 2,3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
- (2018) Todd A Triplett et al. NATURE BIOTECHNOLOGY
- Melanoma
- (2018) Dirk Schadendorf et al. LANCET
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum‐Containing Chemotherapy
- (2017) Erin Larkins et al. ONCOLOGIST
- TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
- (2017) Florie Bertrand et al. Nature Communications
- Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications
- (2017) Niaz Mahmood et al. Oncotarget
- S-adenosyl-methionine (SAM) alters the transcriptome and methylome and specifically blocks growth and invasiveness of liver cancer cells
- (2017) Yan Wang et al. Oncotarget
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- Neuropilin-2 promotes melanoma growth and progression in vivo
- (2016) Whei F. Moriarty et al. MELANOMA RESEARCH
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis
- (2016) Madison Black et al. Oncotarget
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
- (2015) J. Naidoo et al. ANNALS OF ONCOLOGY
- Pharmacological methyl group donors block skeletal metastasisin vitroandin vivo
- (2015) Nicholas Shukeir et al. BRITISH JOURNAL OF PHARMACOLOGY
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- MGDB: a comprehensive database of genes involved in melanoma
- (2015) Di Zhang et al. Database-The Journal of Biological Databases and Curation
- S-adenosylmethionine blocks osteosarcoma cells proliferation and invasionin vitroand tumor metastasisin vivo: therapeutic and diagnostic clinical applications
- (2015) Surabhi Parashar et al. Cancer Medicine
- Long-lasting multifunctional CD8+T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination
- (2015) Florian Wimmers et al. OncoImmunology
- In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
- (2014) C. Wang et al. Cancer Immunology Research
- NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink
- (2013) Olesya A Ulanovskaya et al. Nature Chemical Biology
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Inhibition of angiogenesis by S-adenosylmethionine
- (2011) Mehmet Şahin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of S -adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice
- (2011) Tony W.H. Li et al. CARCINOGENESIS
- Neuropilin-2: a novel biomarker for malignant melanoma?
- (2011) Erica C. Rushing et al. HUMAN PATHOLOGY
- A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo
- (2011) Ronald Goldfarb INTERNATIONAL JOURNAL OF ONCOLOGY
- ConsensusPathDB: toward a more complete picture of cell biology
- (2010) Atanas Kamburov et al. NUCLEIC ACIDS RESEARCH
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA hypomethylation in cancer cells
- (2009) Melanie Ehrlich Epigenomics
- Ethanol inhibits methionine adenosyltransferase II activity and S-adenosylmethionine biosynthesis and enhances caspase-3-dependent cell death in T lymphocytes: relevance to alcohol-induced immunosuppression
- (2007) Prachi T. Hote et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now